Project Details
Description
Working towards targeted therapy in H3K27M tumors: Aurora Kinase Inhibitors and the role of epigenome programing
| Status | Active |
|---|---|
| Effective start/end date | 9/1/20 → 5/31/24 |
Funding
- MAYO CLINIC ROCHESTER
- NATIONAL INSTITUTES OF HEALTH (NIH)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.